There is a need for comprehensive studies of germline mutations in other genes, such as CDH1, PTEN, ATM, and BRIP1. In addition, 2 other high penetrance breast cancer susceptibility genes—STK11 and NF1—have not been reported in the Chinese population. This evidence concerns the gene NF1 and breast carcinoma.